ClinicalTrials.gg
DrugRead study by study

Fulvestrant clinical trials

Also written Faslodex, ZD9238 and ICI 182,780.

studies test it
122
open now
18
in phase 3
23
first study started
1997
ClinicalTrials.gov finds 615 studies for Fulvestrant. How that becomes 122 here

Every study that search finds has been read, apart from the 2 newest, to see whether and how it gives Fulvestrant. ClinicalTrials.gov counts as of Nov 16, 2026. How drug pages count

  1. 615Found by its intervention search · See all 615 hereIt also reads titles, arm labels, keywords and descriptions, and counts the drug’s other names. Of these, 517 name it in an intervention entry. The counts it shows beside each synonym overlap: a study writing two names counts under both.
  2. −7
    Mention it without giving it — earlier treatment, a protocol code, a title naming another drug
  3. 608Give Fulvestrant to participants
  4. −53Observe patients on it, or give it outside a trial
  5. −2Use it as a tool: an imaging tracer or a test of drug response
  6. −29Compare another treatment with it
  7. −402Give it beside what is tested
  8. 122Test it: the count on this site

Get an email when these change. Save the Fulvestrant studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
25 Apr 2002 · FASLODEX · NDA 021344 (FDA, Drugs@FDA)
European Union
9 Mar 2004 · Faslodex · EMEA/H/C/000540 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Fulvestrant
92
Faslodex(ICI 182,780)
5
Fulvestrant injection
3
fulvestrant 500 mg
2

Brand

Faslodex
59
faslodex 500mg
1

Development codes

ZD9238
18
ICI 182,780
7
ICI 182780
5

Studies by the year they started

122 studies that test it; most in 2004 (14)

Studies that test Fulvestrant, by start year
YearStudies
19971
19981
20002
20011
20021
20032
200414
20055
20067
20077
20085
20091
20102
20112
20122
20131
20147
20156
20164
20179
20186
20196
20204
20214
20229
20234
20242
20253
20264

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
14
Phase 2
84
Phase 3
23
Phase 4
4
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 29 · Other 93

AstraZeneca (21) · M.D. Anderson Cancer Center (3) · UNICANCER (3) · Alliance for Clinical Trials in Oncology (3) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (3) · Spanish Breast Cancer Research Group (3) · Fudan University (3) · Memorial Sloan Kettering Cancer Center (2)

Often tested with

Tested in the same studies.

Anastrozole (13) · Palbociclib (7) · Abemaciclib (7) · Tamoxifen (5) · Neratinib (4) · Alpelisib (3) · Olaparib (3) · Ribociclib (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 11 phase 3 studies under way

Fulvestrant is the comparator. A study of two new drugs counts under both.

  • 2Giredestrant · Genentech, Inc., Hoffmann-La Roche · next primary completion Apr 2028
  • 2Letrozole · AstraZeneca, Celcuity Inc · next primary completion Mar 2029
  • 2HRS-8080 · Shandong Suncadia Medicine Co., Ltd. · next primary completion Aug 2027
  • 1Palazestrant · Olema Pharmaceuticals, Inc.
  • 1SIM0270 · Jiangsu Simcere Pharmaceutical Co., Ltd. · next primary completion Aug 2028
  • 1Imlunestrant · Eli Lilly and Company
  • 1Vepdegestrant · Pfizer
  • 1AZD5305 · AstraZeneca · next primary completion Dec 2029
New treatments tested with it · 8 most studied

New when their studies opened, with Fulvestrant beside them; studies of each.

Reaching primary completion within a year · 10, 1 in phase 3

Studies that test Fulvestrant, phase 3 first.

Studies

Open first, then newest update. How each study uses Fulvestrant has had a first review, but it may not be perfect: check the study record before relying on it for anything important, and report a problem from its row. Some give it without naming it in an intervention entry: those were found by reading the record.

Testing it · 122

See all 122 studies that test Fulvestrant →

Behind its US label · 5 — the studies the FDA label of FASLODEX, FULVESTRANT, CLIGAVYX describes

From the Clinical Studies section of FASLODEX (2020-09), FULVESTRANT (2026-03), CLIGAVYX (2026-06), as openFDA has it. A study the site does not hold is left out.

Tested on its own · 38 — no other medicine in its arm

Showing 20 of 38. See all 38 →

Tested with established drugs · 18 — they are given beside it
Tested in a combination · 66 — another drug in the study is under test too

Showing 20 of 66. See all 66 →

Beside an established treatment under test · 54 — an approved drug, surgery or radiation is what the study tests

Tested with Fulvestrant: palbociclib 10 · Alpelisib 9 · Surgery or a procedure 3 · capivasertib 3 · Everolimus 3 · Sirolimus 3 · inavolisib 3 · abemaciclib 2

Showing 20 of 54. See all 54 →

Beside a new treatment under test · 271 — a new drug, cell therapy or vaccine is what the study tests

New treatments tested with Fulvestrant: dalpiciclib 14 · pyrotinib 11 · tucidinostat 8 · capivasertib 6 · culmerciclib 6 · Alpelisib 6 · abemaciclib 5 · inavolisib 5

Showing 20 of 271. See all 271 →

Beside supportive care · 13 — a supportive treatment or test is studied
One option of several · 64 — a test or a strategy chooses among drugs

Showing 20 of 64. See all 64 →

Given beside what is tested · 1 — usual care or a partner of the new treatment
As the comparator · 29 — what is tested is compared with Fulvestrant

Showing 20 of 29. See all 29 →

Observed · 53 — patients on it are followed, or it is given outside a trial

Showing 20 of 53. See all 53 →

As a tool · 2 — an imaging tracer or a test of drug response

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Fulvestrant · ClinicalTrials.gg INT006680

  • MeSH (NLM) D000077267FulvestrantConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 22X328QOC4FULVESTRANTConfirmed FDA, NLM, Wikidata
  • RxNorm 282357Confirmed FDA, Wikidata
  • Wikidata Q5508491fulvestrantConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1379FulvestrantOne source FDA
  • DrugBank DB00947One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Start the discussion